Article info
PDFBasic and translational research
Extended report
Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome
- Correspondence to Hiroyoshi Toyoshiba, Integrated Technology Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Fujisawa City, Kanagawa, 251-8555, Japan; hiroyoshi.toyoshiba{at}takeda.com and Professor Tsutomu Takeuchi, Department of Internal Medicine, Division of Rheumatology, School of Medicine, Keio University, Shinanomachi 35, Shinjyuku, Tokyo 160-8582, Japan; tsutake{at}z5.keio.jp
Citation
Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome
Publication history
- Received November 7, 2016
- Revised March 28, 2017
- Accepted April 9, 2017
- First published May 18, 2017.
Online issue publication
July 11, 2017
Article Versions
- Previous version (18 May 2017).
- Previous version (26 May 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/